Melinta Therapeutics Appoints Lisa DeFrancesco as Senior Vice President of Investor Relations
02. Januar 2018 07:00 ET
|
Melinta Therapeutics
NEW HAVEN, Conn., Jan. 02, 2018 (GLOBE NEWSWIRE) -- Melinta Therapeutics, Inc. (NASDAQ:MLNT), a commercial-stage company discovering, developing, and commercializing novel antibiotics to treat...